Skip Page Header

Home > Surveillance and prevention of hepatitis B and C in Europe.

European Centre for Disease Prevention and Control. (2010) Surveillance and prevention of hepatitis B and C in Europe. Stockholm: ECDC.

[img]
Preview
PDF (ECDC hepatitis B and C in Europe) - Published Version
3MB

ECDC releases two new reports on hepatitis B and C entitled ‘Surveillance and prevention of hepatitis B and C in Europe’ and ‘Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies’.

Hepatitis surveillance is implemented in all Member States but varies considerably across countries. Universal vaccination programmes for HBV are implemented in 22 countries and seven countries have established targeted vaccination programmes.

The majority of the countries have implemented screenings for HBV in pregnant women; only four countries do not have such a programme. Half of the countries conduct screening programmes for hepatitis C, primarily for injecting drug users and prison inmates. Prevalence data on HBV and HCV remain scarce in many countries, both for the general population and groups-at-risk.


Item Type
Report
Date
2010
Pages
143 p.
Publisher
ECDC
Corporate Creators
European Centre for Disease Prevention and Control
Place of Publication
Stockholm
ISBN
978-92-9193-216-0
EndNote
Accession Number
HRB (Electronic Only)
Related URLs

Repository Staff Only: item control page